Japan Digital Health Market Outlook and Forecast to 2033 – Electronic Health Records, Regulatory Approved Apps and Telehealth

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report Download FREE Resources

Published: August 05, 2024 Report Code: GDME0110MDB-ST

Select Item

Japan Digital Health Market Report Overview

The digital health market size in Japan was $556.9 million in 2023. Digital health refers to the utilization of information and communication technologies in medicine and other health-related fields to control diseases and health risks and to encourage well-being. It has a broad scope and includes the use of wearable devices, mobile health, telehealth, health information technology, and telemedicine.

Japan Digital Health Market Outlook, 2023-2033 ($ Million)

Japan Digital Health Market Outlook, 2023-2033 ($ Million)

Buy the Full Report for More Insights into the Japan Digital Health Market Forecast

Download a Free Sample Report

The Japan digital health market research report provides value, volume, and average prices within the market categories from 2018 to 2033. The report also includes a comprehensive analysis of distribution channels, leading companies, and the financial deals landscape within the Japan digital health market.

Market Size (2023) $556.9 million
Historic Period 2018-2022
Forecast Period 2023-2033
Key Segments ·        Electronic Health Records

·        Telehealth

·        Regulatory Approved Apps
Key Companies ·        Cerner Corp

·        Concentrix Corp

·        Siemens Healthineers AG

·        Philips Healthcare Informatics Inc

·        Constellation Software Inc
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Japan Digital Health Market Categories

The key categories in the Japan digital health market are electronic health records, telehealth, and regulatory approved apps. In 2023, the regulatory approved apps was the highest revenue contributor in the Japan digital health market. Regulatory approved apps refer to mobile applications, usually installed on a smart phone or tablet computer, that have been approved by the relevant national regulator to act as a medical device. They are specifically developed for the iOS or android mobile phone platforms. This category is further divided into clinical-focused apps and indication specific apps.

Japan Digital Health Market Analysis by Categories, 2023 (%)

Japan Digital Health Market Analysis by Categories, 2023 (%)

Buy the Full Report for More Category Insights into the Japan Digital Health Market
Download a Free Sample Report

Japan Digital Health Market- Competitive Landscape

A few of the leading companies in Japan digital health market are:

  • Cerner Corp
  • Concentrix Corp
  • Siemens Healthineers AG
  • Philips Healthcare Informatics Inc
  • Constellation Software Inc

In 2023, Cerner Corp was the highest revenue contributor in the Japan digital health market. Headquartered in North Kansas City, Missouri, the US, Cerner Corp, a subsidiary of Oracle Corporation, is a provider of healthcare information technology solutions and related services. The company offers a comprehensive range of solutions and services that assist the clinical, financial, and operational needs of organizations. Its major solutions include ambulatory, critical care, acute EHR solutions, women’s health, customer relationship management, patient engagement, and revenue cycle management. Furthermore, the company offers solutions on the unified Cerner Millennium architecture and the HealtheIntent cloud-based platform.

Japan Digital Health Market Analysis by Companies, 2023 (%)

Japan Digital Health Market Analysis by Companies, 2023 (%)

Buy the Full Report for More Company Insights into the Japan Digital Health Market
Download a Free Sample Report

 

Segments Covered in the Report

Japan Digital Health Segment Outlook (Value, $ Million, 2018-2033)

  • Electronic Health Records
  • Telehealth
  • Regulatory Approved Apps

Scope

The Japan digital health market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.

  • 2023 company share and distribution share data for the digital health market.

  • Global corporate-level profiles of key companies operating within the Japan digital health market. Based on the availability of data for the particular category and country, information related to pipeline products, news, and deals is also available in the report.

Reasons to Buy

  • Business strategies by identifying the key market segments poised for strong growth in the future.

  • Develop market-entry and market expansion strategies.

  • Design competition strategies by identifying who-stands-where in the market.

  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

  • Understand the key distribution channels and what’s the most preferred mode of product distribution – identify, understand and capitalize.

Key companies covered in the “Japan Digital Health Outlook to 2033” report:
• Cerner Corp
• Concentrix Corp
• Teladoc Health Inc

Table of Contents

|1 Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 7

|1.2 List of Figures 8

2 Introduction 9

2.1 What Is This Report About? 9

2.2 Digital Health Market Segmentation 9

2.3 Definitions of Markets Covered in the Report 10

3 Digital Health Market, Japan 13

3.1 Digital Health Market, Japan, Revenue ($m), 2018-2033 13

3.2 Digital Health Market, Japan, Revenue Mix ($m), 2023 15

3.3 Digital Health Market, Japan, Category Contribution by Revenue ($m), 2023 16

3.4 Digital Health Market, Japan, Revenue ($m), 2018-2033 18

3.5 Digital Health Market, Japan, Volume (Units), 2018-2033 20

3.6 Digital Health Market, Japan, Volume (Units), 2018-2033 22

3.7 Digital Health Market, Japan, Company Share by Revenue ($m), 2023 25

4 Electronic Health Records Market, Japan 27

4.1 Electronic Health Records Market, Japan, Revenue Mix ($m), 2023 27

4.2 Electronic Health Records Market, Japan, Segment Contribution (%), 2023 28

4.3 Electronic Health Records Market, Japan, Revenue ($m), 2018-2033 30

4.4 Electronic Health Records Market, Japan, Volume (Units), 2018-2033 32

4.5 Electronic Health Records Market, Japan, Average Price ($), 2018-2033 34

4.6 Electronic Health Records Market, Japan, Distribution Share by Revenue ($m), 2023 35

4.7 Electronic Health Records Market, Japan, Company Share by Revenue ($m), 2023 36

5 Regulatory Approved Apps Market, Japan 37

5.1 Regulatory Approved Apps Market, Japan, Revenue Mix ($m), 2023 37

5.2 Regulatory Approved Apps Market, Japan, Segment Contribution (%), 2023 38

5.3 Regulatory Approved Apps Market, Japan, Revenue ($m), 2018-2033 40

5.3.1 Clinical-Focused Apps Market, Japan, Revenue ($m), by Segment, 2018-2033 42

5.3.2 Indication Specific Mobile Apps Market, Japan, Revenue ($m), by Segment, 2018-2033 44

5.4 Regulatory Approved Apps Market, Japan, Volume (Units), 2018-2033 46

5.4.1 Clinical-Focused Apps Market, Japan, Volume (Units), by Segment, 2018-2033 48

5.4.2 Indication Specific Mobile Apps Market, Japan, Volume (Units), by Segment, 2018-2033 50

5.5 Regulatory Approved Apps Market, Japan, Average Price ($) , 2018-2033 52

5.6 Regulatory Approved Apps Market, Japan, Distribution Share by Revenue ($m), 2023 53

5.7 Regulatory Approved Apps Market, Japan, Company Share by Revenue ($m), 2023 54

6 Telehealth Market, Japan 55

6.1 Telehealth Market, Japan, Revenue Mix ($m), 2023 55

6.2 Telehealth Market, Japan, Segment Contribution (%), 2023 56

6.3 Telehealth Market, Japan, Revenue ($m), 2018-2033 58

6.4 Telehealth Market, Japan, Volume (Units), 2018-2033 60

6.5 Telehealth Market, Japan, Average Price ($) , 2018-2033 62

6.6 Telehealth Market, Japan, Distribution Share by Revenue ($m), 2023 63

6.7 Telehealth Market, Japan, Company Share by Revenue ($m), 2023 64

7 Overview of Key Companies in Japan, Digital Health Market 65

7.1 Siemens Healthineers AG 65

7.1.1 Company Overview 65

7.2 Cerner Corp 65

7.2.1 Company Overview 65

7.3 Philips Healthcare Informatics Inc 65

7.3.1 Company Overview 65

7.4 Concentrix Corp 66

7.4.1 Company Overview 66

7.5 Constellation Software Inc 66

7.5.1 Company Overview 66

8 Digital Health Market Pipeline Products 67

9 Financial Deals Landscape 71

9.1 Acquisition 71

9.1.1 Valor Holdings to Acquire

24.99% Stake in M-aid for USD1.96 Million 71

9.1.2 TIS to Acquire Resco 72

9.1.3 Suzuken to Acquire

16.61% Stake in Welby from Digital Garage for USD9.89 Million 73

9.1.4 Glad Cube to Acquire Workhouse for Approximately USD0.67 Million 75

9.1.5 Medinet Invests in Kokoro Mill 76

9.2 Asset Transactions 77

9.2.1 Smaregi Acquires Rece One Plus Business From Ligua for USD1.14 Million 77

9.3 Equity Offerings 78

9.3.1 JMDC to Raise USD0.04 Million in Rights Offering 78

9.4 Partnerships 79

9.4.1 Astellas Pharma to Enter into Agreement with YASKAWA Electric 79

9.4.2 Ybrain to Enter into Co-Development with Meditrix 80

9.4.3 NTT and Red Hat Partner Form Partnership with Nvidia and Fujitsu 81

9.4.4 Vivtex Enters into Agreement with Astellas Pharma 83

9.4.5 SyntheticGestalt Enters into Agreement with Enamine 84

9.4.6 SMK Enters into Licensing Agreement with Canary Speech 86

9.4.7 Vista.ai Enters into Agreement with HekaBio 87

9.5 Venture Financing 88

9.5.1 Atlast Health (Attrust Health) Secures Series A Financing 88

9.5.2 digzyme Secures USD4.71 Million in Series A round 90

9.5.3 CareCraft Secures USD0.64 Million in Seed Financing 91

9.5.4 VALT Japan to Raise USD1.9 Million in Pre-Series B Venture Funding 92

9.5.5 Hokuto Raises USD5.98 Million in Venture Funding 94

9.5.6 M-INT Raises USD0.59 Million in Pre-Series A Financing 96

9.5.7 Second Heart Secures Venture Funding 97

9.5.8 Aillis Secures Series D Funding 98

9.5.9 Pleap Raises Funds through Pre-Seed Financing 99

9.5.10 Genon Raises USD0.84 Million in Seed Financing 100

9.5.11 One Medica Secures USD2.4 Million in Series A Funding 101

9.5.12 Hedgehog MedTech Raises USD3.38 Million in Series A Financing 102

9.5.13 Miniique (Miniiku) Secures USD0.93 Million in Pre-Series A Funding 104

9.5.14 Periotherapia (Periotherapy) Secures USD2.40 Million in Venture Financing 106

9.5.15 PlatinumBio (PtBio) Secures USD3.34 Million in Series A Financing 107

9.5.16 GramEye Secures Funding in Series A Financing 109

9.5.17 CaTe Secures USD2.89 Million in Series A Financing 110

10 Recent Developments 111

10.1 Corporate Communications 111

10.1.1 May 29, 2024: Marubeni Announces Personnel Changes of Executive Officers 111

10.1.2 May 22, 2024: Towa Pharmaceutical Notice of Changes in Officers 111

10.1.3 May 17, 2024: Merit Medical Systems Receives 510(K) Clearance For Siege Vascular Plug 111

10.1.4 Mar 18, 2024: NTT DOCOMO Appoints New Management Team 111

10.1.5 Feb 06, 2024: Yokogawa Electric Notice Concerning Appointment of Officers 112

10.1.6 Jan 08, 2024: OpenText Names Denise Miura as SVP and President of OpenText Japan 112

10.1.7 Dec 19, 2023: Prof. Dr. Tony James Joins Lifecare’s Scientific Advisory Board 112

10.1.8 Nov 23, 2023: Purple Transform Appoints Simon Blagden as Advisory Board Member 112

10.1.9 Nov 02, 2023: Safe & Green Holdings Corp. Announces Appointment of Thomas Meharey to the Company’s Board of Directors 113

10.1.10 Oct 25, 2023: Glooko Appoints Enrique Conterno, former Eli Lilly & Company Senior Executive, to Board of Directors 113

10.1.11 Sep 06, 2023: Dataiku Appoints Krish Venkataraman as President 114

10.2 Financial Announcements 114

10.2.1 May 28, 2024: Foresight Reports Q1 2024 Results 114

10.2.2 May 07, 2024: Yokogawa Electric Announces Financial Results for Fiscal Year 2023 116

10.2.3 May 02, 2024: Marubeni Corporation Notice Regarding the Recording of Extraordinary Losses in the Non-Consolidated Financial Statements for the Fiscal Year Ended March 2024 116

10.2.4 Feb 22, 2024: Owlet Announces Strong Preliminary Fourth Quarter 2023 Results and to Report Fourth Quarter 2023 Financial Results on March 7, 2024 116

10.2.5 Feb 14, 2024: Sawai Group Holdings Announces Summary of Financial Results for the Third Quarter 2024 117

10.2.6 Feb 08, 2024: Fujifilm Announces the Financial Results for the Third Quarter Ended December 31, 2023 117

10.2.7 Feb 06, 2024: INSERTING and REPLACING GE HealthCare Reports Fourth Quarter and Full Year 2023 Financial Results 118

10.2.8 Jan 08, 2024: iCardio.ai Partners with Major PACS UltraLinQ to Enhance Ultrasound Imaging Interpretation 122

10.2.9 Dec 12, 2023: Lisata Therapeutics Announces Completion of Enrollment in Phase 2b ASCEND Trial of LSTA1 in Metastatic Pancreatic Ductal Adenocarcinoma 123

10.2.10 Nov 17, 2023: Pixie Dust Technologies Reports Fiscal Year 2023 Results 124

10.2.11 Nov 08, 2023: Fujifilm Reports Results for H1 Ended September 30, 2023 125

10.2.12 Oct 31, 2023: GE HealthCare Reports Third Quarter 2023 Financial Results 126

10.2.13 Sep 27, 2023: R.A.W. Receives 510(k) Clearance for Ablation-Fit 127

10.2.14 Aug 23, 2023: Foresight Posts Q2 2023 Financial Results 128

10.2.15 Aug 22, 2023: SyntheticMR Announces Interim Report April – June 2023 129

10.2.16 Aug 14, 2023: Port Announces FY2024 Q1 Financial Results 129

10.2.17 Aug 09, 2023: Sawai Group Holdings Announces Summary of Financial Results for the First Quarter 2024 130

10.2.18 Aug 09, 2023: Fujifilm Posts Results for Q1 Ended June 30, 2023 130

10.2.19 Aug 09, 2023: Fujifilm Reports Results for Q1 Ended June 30, 2023 131

10.2.20 Aug 09, 2023: DeNA Announces Consolidated Financial Results for the Three Months Ended June 30, 2023 132

10.2.21 Aug 08, 2023: Yokogawa Electric Announces Presentation Materials of Financial Results for the First Quarter of Fiscal Year 2023 133

10.2.22 Aug 08, 2023: Dai Nippon Printing Announces Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2024 133

10.2.23 Aug 04, 2023: Marubeni Corp. Announces Consolidated financial results for the three-month period ended June 30, 2023 133

10.2.24 Aug 01, 2023: JVCKENWOOD Announces Consolidated Financial Results for the First Three Months Ending March 31, 2024 133

10.2.25 Jun 20, 2023: Genesis Air Receives 510(k) Clearance for RGS Air Purifier 134

10.3 Government and Public Interest 134

10.3.1 Feb 14, 2024: GE HealthCare Management to Present at Upcoming Investor Conferences 134

10.4 Other Significant Developments 135

10.4.1 May 09, 2024: Takeda Announces Enterprise-Wide Program to Support Growth and Deliver Core Operating Profit Margin Improvement 135

10.4.2 Mar 12, 2024: Japanese Multinational Biopharmaceutical Company Selects ValGenesis iRisk for Implementing ICH Q14 Framework 135

10.4.3 Feb 02, 2024: Academic Report by Pixie Dust Technologies Showcases Applicability of Gamma Wave Sound 136

10.4.4 Jan 09, 2024: Announcement of Commencement of DTx Distribution Platform Construction for the Promotion of Digital Therapeutic Services 136

10.4.5 Nov 22, 2023: Notice Regarding Approval for Resolutions Related to Share Consolidation, and the Abolition of the Provision on Share Units, and Partial Amendment to the Articles of Incorporation 137

10.4.6 Aug 07, 2023: Healthpoint celebrates milestone of 100 robotically assisted surgeries 138

10.4.7 Jun 27, 2023: National Cancer Center and Department of Medical Services, Ministry of Public Health of Thailand sign Memorandum of Cooperation to Promote Cross-border Online Clinical Trials 138

10.5 Product News 140

10.5.1 Mar 20, 2024: Ubie Launches Checkup Platform for Patient Self-Monitoring, Medication Management and Improved Provider Communication 140

10.5.2 Feb 02, 2024: Academic Presentation at Neuroscience 2023 in the United States – Confirmation of Gamma Wave Synchronization in the Human Brain through Auditory Stimulation- 141

10.5.3 Nov 27, 2023: Canon Medical Introduces End-to-End CT Workflow Automation, Advancing Healthcare Operational Efficiency 142

10.5.4 Oct 23, 2023: Researchers Develop Danger Analysis Tool for the Safer Design of Gene Editing 142

10.5.5 Sep 20, 2023: Icon Releases Expanded End-to-End Clinical Trial Tokenisation Solution 143

10.5.6 Jun 26, 2023: ICON Releases Latest Version of its Digital Platform, Providing Integrated Patient Services and Harmonised Data in One Platform 144

10.6 Strategy And Business Planning 145

10.6.1 May 21, 2024: Astellas Announces a Collaboration with YASKAWA to Create an Innovative Cell Therapy Ecosystem through the Integration of Pharmaceutical and Robotics Technologies 145

10.6.2 Dec 05, 2023: Sysmex to Reinforce IVD Instrument Production to Support Total Solutions in Clinical Testing 145

10.6.3 Nov 28, 2023: Cleveland Clinic and Canon to develop medical imaging tech 146

10.6.4 Nov 13, 2023: PHC Corporation Announces That Indonesia-Based Life Science Equipment Subsidiary Established in March by PHC Group Will Begin Full-Scale Operations 146

10.6.5 Oct 12, 2023: Hitachi Announces Consolidation of Healthcare Business Into Hitachi High-Tech Through Company Split 147

10.6.6 Oct 11, 2023: Gunze to Invest

5.7 Billion Jpy to Expand Konan Plant in Japan for Growth of Engineering Plastics Business 148

10.6.7 Sep 14, 2023: Fujitsu and Baptist Health South Florida Transform Operating Room Scheduling with Newly Launched Solution to Boost Utilization Rates and the Financial Health of the Surgical Discipline 148

10.6.8 Aug 15, 2023: Konica Minolta Selected to Exhibit Cloud-based Workflow Automation Platform at Vizient Innovative Technology Exchange 149

10.6.9 Aug 15, 2023: Mental Health Technologies Announces Alliance With Meditab Software 149

10.6.10 Jun 23, 2023: Aptar Digital Health and Tasso Collaboration Increases Access to Services for Clinical Trials 150

10.6.11 Jun 22, 2023: Shyld and Shimadzu Corporation Team Up With the Goal of Revolutionizing Healthcare With Groundbreaking AI-Powered UV-C Disinfection Technology 150

10.6.12 Jun 20, 2023: Flatiron Health Announces New Partnership in the UK 151

10.6.13 Jun 19, 2023: Developing a Disinfection System by UV Irradiation Robot Announce Strategic Partnership With a Silicon Valley Startup Company 151

10.6.14 Jun 18, 2023: M42 and QST Collaborate to Share Research on Carbon Ion Therapy 152

11 Appendix 153

11.1 Research Methodology 154

11.1.1 Coverage 154

11.1.2 Secondary Research 154

11.1.3 Primary Research 155

11.1.4 Market Modeling and Forecasting 156

11.1.5 Company Share Analysis 157

11.1.6 Distribution Share Analysis 157

11.1.7 Benchmarking 158

11.2 GlobalData Consulting 158

11.3 Contact Us 158

11.4 Disclaimer 159

Table

|1.1 List of Tables

Table 1: Digital Health Market, Japan, Revenue ($m), USD Constant, 2018-2033 14

Table 2: Digital Health Market, Japan, Category Contribution by Revenue ($m), 2023 17

Table 3: Digital Health Market, Japan, Revenue ($m), USD Constant, Historic, 2018-2033 19

Table 4: Digital Health Market, Japan, Volume (Units), 2018-2033 21

Table 5: Digital Health Market, Japan, Volume (Units), Historic, 2018-2033 24

Table 6: Digital Health Market, Japan, Company Share by Revenue ($m), USD Constant, 2023 26

Table 7: Electronic Health Records Market, Japan, Segment Contribution (%), 2023 29

Table 8: Electronic Health Records Market, Japan, Revenue ($m), USD Constant, 2018-2033 31

Table 9: Electronic Health Records Market, Japan, Volume (Units), 2018-2033 33

Table 10: Electronic Health Records Market, Japan, Average Price ($), 2018-2033 34

Table 11: Electronic Health Records Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2023 35

Table 12: Electronic Health Records Market, Japan, Company Share by Revenue ($m), USD Constant, 2023 36

Table 13: Regulatory Approved Apps Market, Japan, Segment Contribution (%), 2023 39

Table 14: Regulatory Approved Apps Market, Japan, Revenue ($m), USD Constant, 2018-2033 41

Table 15: Clinical-Focused Apps Market, Japan, Revenue ($m), USD Constant, 2018-2033 43

Table 16: Indication Specific Mobile Apps Market, Japan, Revenue ($m), USD Constant, 2018-2033 45

Table 17: Regulatory Approved Apps Market, Japan, Volume (Units), 2018-2033 47

Table 18: Clinical-Focused Apps Market, Japan, Volume (Units), 2018-2033 49

Table 19: Indication Specific Mobile Apps Market, Japan, Volume (Units), 2018-2033 51

Table 20: Regulatory Approved Apps Market, Japan, Average Price ($), 2018-2033 52

Table 21: Regulatory Approved Apps Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2023 53

Table 22: Regulatory Approved Apps Market, Japan, Company Share by Revenue ($m), USD Constant, 2023 54

Table 23: Telehealth Market, Japan, Segment Contribution (%), 2023 57

Table 24: Telehealth Market, Japan, Revenue ($m), USD Constant, 2018-2033 59

Table 25: Telehealth Market, Japan, Volume (Units), 2018-2033 61

Table 26: Telehealth Market, Japan, Average Price ($), 2018-2033 62

Table 27: Telehealth Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2023 63

Table 28: Telehealth Market, Japan, Company Share by Revenue ($m), USD Constant, 2023 64

Table 29: Digital Health Market Pipeline Products 67

Table 30: Valor Holdings to Acquire 24.99% Stake in M-aid for USD1.96 Million 71

Table 31: TIS to Acquire Resco 72

Table 32: Suzuken to Acquire 16.61% Stake in Welby from Digital Garage for USD9.89 Million 73

Table 33: Glad Cube to Acquire Workhouse for Approximately USD0.67 Million 75

Table 34: Medinet Invests in Kokoro Mill 76

Table 35: Smaregi Acquires Rece One Plus Business From Ligua for USD1.14 Million 77

Table 36: JMDC to Raise USD0.04 Million in Rights Offering 78

Table 37: Astellas Pharma to Enter into Agreement with YASKAWA Electric 79

Table 38: Ybrain to Enter into Co-Development with Meditrix 80

Table 39: NTT and Red Hat Partner Form Partnership with Nvidia and Fujitsu 81

Table 40: Vivtex Enters into Agreement with Astellas Pharma 83

Table 41: SyntheticGestalt Enters into Agreement with Enamine 84

Table 42: SMK Enters into Licensing Agreement with Canary Speech 86

Table 43: Vista.ai Enters into Agreement with HekaBio 87

Table 44: Atlast Health (Attrust Health) Secures Series A Financing 88

Table 45: digzyme Secures USD4.71 Million in Series A round 90

Table 46: CareCraft Secures USD0.64 Million in Seed Financing 91

Table 47: VALT Japan to Raise USD1.9 Million in Pre-Series B Venture Funding 92

Table 48: Hokuto Raises USD5.98 Million in Venture Funding 94

Table 49: M-INT Raises USD0.59 Million in Pre-Series A Financing 96

Table 50: Second Heart Secures Venture Funding 97

Table 51: Aillis Secures Series D Funding 98

Table 52: Pleap Raises Funds through Pre-Seed Financing 99

Table 53: Genon Raises USD0.84 Million in Seed Financing 100

Table 54: One Medica Secures USD2.4 Million in Series A Funding 101

Table 55: Hedgehog MedTech Raises USD3.38 Million in Series A Financing 102

Table 56: Miniique (Miniiku) Secures USD0.93 Million in Pre-Series A Funding 104

Table 57: Periotherapia (Periotherapy) Secures USD2.40 Million in Venture Financing 106

Table 58: PlatinumBio (PtBio) Secures USD3.34 Million in Series A Financing 107

Table 59: GramEye Secures Funding in Series A Financing 109

Table 60: CaTe Secures USD2.89 Million in Series A Financing 110

Table 61: Total Number of Primary Research Participants, Digital Health Market, by Country 155

Figures

|1.2 List of Figures

Figure 1: Digital Health Market, Japan, Revenue ($m), USD Constant, 2018-2033 13

Figure 2: Digital Health Market, Japan, Revenue Mix ($m), 2023 15

Figure 3: Digital Health Market, Japan, Category Contribution (%), 2023 16

Figure 4: Digital Health Market, Japan, Revenue ($m), USD Constant, Historic, 2018-2033 18

Figure 5: Digital Health Market, Japan, Volume (Units), 2018-2033 20

Figure 6: Digital Health Market, Japan, Volume (Units), Historic, 2018-2033 22

Figure 7: Digital Health Market, Japan, Company Share (%) 2023 25

Figure 8: Electronic Health Records Market, Japan, Revenue Mix ($m), 2023 27

Figure 9: Electronic Health Records Market, Japan, Segment Contribution (%), 2023 28

Figure 10: Electronic Health Records Market, Japan, Revenue ($m), USD Constant, 2018-2033 30

Figure 11: Electronic Health Records Market, Japan, Volume (Units), 2018-2033 32

Figure 12: Electronic Health Records Market, Japan, Company Share (%) 2023 36

Figure 13: Regulatory Approved Apps Market, Japan, Revenue Mix ($m), 2023 37

Figure 14: Regulatory Approved Apps Market, Japan, Segment Contribution (%), 2023 38

Figure 15: Regulatory Approved Apps Market, Japan, Revenue ($m), USD Constant, 2018-2033 40

Figure 16: Clinical-Focused Apps Market, Japan, Revenue ($m), USD Constant, 2018-2033 42

Figure 17: Indication Specific Mobile Apps Market, Japan, Revenue ($m), USD Constant, 2018-2033 44

Figure 18: Regulatory Approved Apps Market, Japan, Volume (Units), 2018-2033 46

Figure 19: Clinical-Focused Apps Market, Japan, Volume (Units), 2018-2033 48

Figure 20: Indication Specific Mobile Apps Market, Japan, Volume (Units), 2018-2033 50

Figure 21: Regulatory Approved Apps Market, Japan, Company Share (%) 2023 54

Figure 22: Telehealth Market, Japan, Revenue Mix ($m), 2023 55

Figure 23: Telehealth Market, Japan, Segment Contribution (%), 2023 56

Figure 24: Telehealth Market, Japan, Revenue ($m), USD Constant, 2018-2033 58

Figure 25: Telehealth Market, Japan, Volume (Units), 2018-2033 60

Figure 26: Telehealth Market, Japan, Company Share (%) 2023 64

Frequently asked questions

Japan Digital Health Market Outlook and Forecast to 2033 – Electronic Health Records, Regulatory Approved Apps and Telehealth standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Japan Digital Health Market Outlook and Forecast to 2033 – Electronic Health Records, Regulatory Approved Apps and Telehealth was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Digital Health reports
Medical Devices
New
Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…
$495 | July 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Medical Devices
New
Traditional Wound Management Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | June 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Japan Digital Health Market Outlook and Forecast to 2033 – Electronic Health Records, Regulatory Approved Apps and Telehealth in real time.

  • Access a live Japan Digital Health Market Outlook and Forecast to 2033 – Electronic Health Records, Regulatory Approved Apps and Telehealth dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more